Literature DB >> 6115521

[Metabolic and hormonal response to physical exercise under acute beta 1-adrenergic blockade (author's transl)].

W Kindermann, W M Schmitt, G Biro, A Schnabel.   

Abstract

In 14 healthy physical education students the effect of acute beta 1-adrenergic blockade (100 mg metoprolol) on maximal and prolonged exercise capacity, carbohydrate and lipid metabolism, catecholamines, insulin, growth hormone, and cortisol was studied in a double-blind trial. Metoprolol had no effect on maximal oxygen uptake. The 3.5% reduction of maximal exercise capacity had to be attributed to the reduced maximal lactate concentration. Maximal heart rate was reduced by approximately 22%. At submaximal work loads (treadmill) exercise with gradually increasing velocity), lipolysis appeared to be inhibited, arterial glucose and lactate concentrations were unaffected. With metoprolol, epinephrine levels at rest and submaximal work loads were elevated; no effect was apparent at maximal loads. Norepinephrine, insulin, growth hormone, and cortisol were unaffected in exercise with increasing work loads. In prolonged exercise at a constant load of approximately 70% of maximal exercise capacity, mean heart rate was reduced by 26%. Arterial lactate and glucose levels were essentially unchanged, free fatty acids and glycerol decreased by 50 and 30% respectively. With metoprolol, epinephrine increased by 100%, norepinephrine by 50% growth hormone by 60%, and cortisol by 90%, insulin remained unchanged. The results indicate that a reduction of exercise capacity by beta 1-adrenergic blockade in patients undergoing an endurance type training for therapeutic or rehabilitative purposes is unlikely to occur. The inhibition of lipolysis under metoprolol appears to be counteracted by the increased carbohydrate utilisation and by the increased secretion of the regulating hormones.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115521

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  10 in total

1.  The effect of verapamil on cardiovascular and metabolic responses to exercise.

Authors:  H Petri; B G Arends; M A van Baak
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

2.  Physical performance and serum potassium under chronic beta-blockade.

Authors:  T Kullmer; W Kindermann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

3.  Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol.

Authors:  M van Baak; W Jennen; F T Verstappen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Beta-adrenoceptor blocking agents and lipolysis.

Authors:  H H Harms; J De Vente; J Zaagsma
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Influence of xamoterol, a partial beta 1-selective agonist, on physical performance capacity and cardiocirculatory, metabolic and hormonal parameters.

Authors:  T Kullmer; W Kindermann; A Urhausen; M Hess
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 6.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

Review 7.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136

8.  [Catecholamine excretion during physical exercise and mental performance].

Authors:  M Lehmann; G Huber; M Spöri; J Keul
Journal:  Int Arch Occup Environ Health       Date:  1982       Impact factor: 3.015

9.  [Plasma dopamine, noradrenaline and adrenaline response during cardiac and peripheral-muscular exhaustion].

Authors:  M Lehmann; R Kapp; U Spöri; J Keul
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

10.  Metabolic and hormonal responses to exhaustive supramaximal running with and without beta-adrenergic blockade.

Authors:  A Schnabel; W Kindermann; V Steinkraus; O Salas-Fraire; G Biro
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1984
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.